TY - JOUR
T1 - Genome-wide miRNA expression profiling of molecular subgroups of peripheral T-cell lymphoma
AU - Lone, Waseem
AU - Bouska, Alyssa
AU - Sharma, Sunandini
AU - Amador, Catalina
AU - Saumyaranjan, Mallick
AU - Herek, Tyler A.
AU - Heavican, Tayla B.
AU - Yu, Jiayu
AU - Lim, Soon Thye
AU - Ong, Choon Kiat
AU - Slack, Graham W.
AU - Savage, Kerry J.
AU - Rosenwald, Andreas
AU - Ott, German
AU - Cook, James R.
AU - Feldman, Andrew L.
AU - Rimsza, Lisa M.
AU - McKeithan, Timothy W.
AU - Greiner, Timothy C.
AU - Weisenburger, Dennis D.
AU - Melle, Federica
AU - Motta, Giovanna
AU - Pileri, Stefano
AU - Vose, Julie M.
AU - Chan, Wing C.
AU - Iqbal, Javeed
N1 - Funding Information:
The authors thank the University of Nebraska Medical Center Human Genetics Laboratory at the Munroe-Meyer Institute for facilitating us to scan our nCounter-cartridges on the digital analyzer and the University of Nebraska Medical Center Flow Cytometry Core. This work would not be possible without support provided by NIH NCI grants UH2 CA206127 -02 (to J. Iqbal and W.C. Chan) and P01 CA229100 (to J. Iqbal), the Leukemia and Lymphoma Society (TRP-6129–04; to J. Iqbal), NIH NCI Eppley Cancer Center Support grant P30 CA036727 (to J. Iqbal), NIH NCI Strategic Partnering to Evaluate Cancer Signatures (SPECS) II 5 UO1 CA157581–01 (to L.M. Rimsza, J. Iqbal, W.C. Chan), NIH NCI Specialized Programs of Research Excellence 1P50 CA136411–01 01A1 PP-4, and City of Hope internal funds (W.C.C.), AIRC 5 ⨯ 1000 grant (no. 21198; to S. Pileri). This study is also supported by Singapore Ministry of Health’s National Medical Research Council, NMRC OF-LCG (MOH-000205–00) and TANOTO and LING Foundation (NRDUKSN18101; to C.K. Ong, S.T. Lim).
Funding Information:
The authors thank the University of Nebraska Medical Center Human Genetics Laboratory at the Munroe-Meyer Institute for facilitating us to scan our nCounter-cartridges on the digital analyzer and the University of Nebraska Medical Center Flow Cytometry Core. This work would not be possible without support provided by NIH NCI grants UH2 CA206127 -02 (to J. Iqbal and W.C. Chan) and P01 CA229100 (to J. Iqbal), the Leukemia and Lymphoma Society (TRP-6129-04; to J. Iqbal), NIH NCI Eppley Cancer Center Support grant P30 CA036727 (to J. Iqbal), NIH NCI Strategic Partnering to Evaluate Cancer Signatures (SPECS) II 5 UO1 CA157581-01 (to L.M. Rimsza, J. Iqbal, W.C. Chan), NIH NCI Specialized Programs of Research Excellence 1P50 CA136411-01 01A1 PP-4, and City of Hope internal funds (W.C.C.), AIRC 5 ? 1000 grant (no. 21198; to S. Pileri). This study is also supported by Singapore Ministry of Health's National Medical Research Council, NMRC OF-LCG (MOH-000205-00) and TANOTO and LING Foundation (NRDUKSN18101; to C.K. Ong, S.T. Lim).
Publisher Copyright:
© 2021 American Association for Cancer Research
PY - 2021/11/15
Y1 - 2021/11/15
N2 - Purpose: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of non-Hodgkin lymphomas with aggressive clinical behavior. We performed comprehensive miRNA profiling in PTCLs and corresponding normal CD4+ Th1/2 and TFH-like polarized subsets to elucidate the role of miRNAs in T-cell lymphomagenesis. Experimental Design: We used nCounter (NanoString Inc) for miRNA profiling and validated using Taqman qRT-PCR (Applied Biosystems, Inc). Normal CD4+ T cells were polarized into effector Th subsets using signature cytokines, and miRNA significance was revealed using functional experiments. Results: Effector Th subsets showed distinct miRNA expression with corresponding transcription factor expression (e.g., BCL6/miR-19b, -106, -30d, -26b, in IL21-polarized; GATA3/miR-155, miR-337 in Th2-polarized; and TBX21/miR-181a, -331-3p in Th1-polarized cells). Integration of miRNA signatures suggested activation of TCR and PI3K signaling in IL21-polarized cells, ERK signaling in Th1-polarized cells, and AKT-mTOR signaling in Th2-polarized cells, validated at protein level. In neoplastic counterparts, distinctive miRNAs were identified and confirmed in an independent cohort. Integrative miRNA-mRNA analysis identified a decrease in target transcript abundance leading to deregulation of sphingolipid and Wnt signaling and epigenetic dysregulation in angioimmunoblastic T-cell lymphoma (AITL), while ERK, MAPK, and cell cycle were identified in PTCL subsets, and decreased target transcript abundance was validated in an independent cohort. Elevated expression of miRNAs (miR-126-3p, miR-145-5p) in AITL was associated with poor clinical outcome. In silico and experimental validation suggest two targets (miR-126! SIPR2 and miR-145 → ROCK1) resulting in reduced RhoA-GTPase activity and T-B-cell interaction. Conclusions: Unique miRNAs and deregulated oncogenic pathways are associated with PTCL subtypes. Upregulated miRNA-126-3p and miR-145-5p expression regulate RhoA-GTPase and inhibit T-cell migration, crucial for AITL pathobiology.
AB - Purpose: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of non-Hodgkin lymphomas with aggressive clinical behavior. We performed comprehensive miRNA profiling in PTCLs and corresponding normal CD4+ Th1/2 and TFH-like polarized subsets to elucidate the role of miRNAs in T-cell lymphomagenesis. Experimental Design: We used nCounter (NanoString Inc) for miRNA profiling and validated using Taqman qRT-PCR (Applied Biosystems, Inc). Normal CD4+ T cells were polarized into effector Th subsets using signature cytokines, and miRNA significance was revealed using functional experiments. Results: Effector Th subsets showed distinct miRNA expression with corresponding transcription factor expression (e.g., BCL6/miR-19b, -106, -30d, -26b, in IL21-polarized; GATA3/miR-155, miR-337 in Th2-polarized; and TBX21/miR-181a, -331-3p in Th1-polarized cells). Integration of miRNA signatures suggested activation of TCR and PI3K signaling in IL21-polarized cells, ERK signaling in Th1-polarized cells, and AKT-mTOR signaling in Th2-polarized cells, validated at protein level. In neoplastic counterparts, distinctive miRNAs were identified and confirmed in an independent cohort. Integrative miRNA-mRNA analysis identified a decrease in target transcript abundance leading to deregulation of sphingolipid and Wnt signaling and epigenetic dysregulation in angioimmunoblastic T-cell lymphoma (AITL), while ERK, MAPK, and cell cycle were identified in PTCL subsets, and decreased target transcript abundance was validated in an independent cohort. Elevated expression of miRNAs (miR-126-3p, miR-145-5p) in AITL was associated with poor clinical outcome. In silico and experimental validation suggest two targets (miR-126! SIPR2 and miR-145 → ROCK1) resulting in reduced RhoA-GTPase activity and T-B-cell interaction. Conclusions: Unique miRNAs and deregulated oncogenic pathways are associated with PTCL subtypes. Upregulated miRNA-126-3p and miR-145-5p expression regulate RhoA-GTPase and inhibit T-cell migration, crucial for AITL pathobiology.
UR - http://www.scopus.com/inward/record.url?scp=85119056223&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119056223&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-21-0573
DO - 10.1158/1078-0432.CCR-21-0573
M3 - Article
C2 - 34426436
AN - SCOPUS:85119056223
SN - 1078-0432
VL - 27
SP - 6039
EP - 6053
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 21
ER -